AURKA and colorectal carcinoma: In both tumor types, Myc has been found to induce Aurora A kinase, and thus it may be hypothesized that the more synergistic combination effects demonstrated in select CRC models could be due to MEK inhibitor mediated degradation of c-Myc leading to more robust effects on Aurora A.